PE/VC  Abingworth

     Office Locations:

3000 Sand Hill Road
Bldg. 1, Suite 145
Menlo Park, CA 94025
Phone: 650-926-0600
Fax: 650-926-9782

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.


  • Early
  • Expansion
  • Growth
  • Late
  • Middle Market



  • Life Sciences & Healthcare
  • Medical Device



    Founded in 1973, Abingworth is an international investment group dedicated exclusively to the life sciences and healthcare sectors. The company invests across all stages of company development including early and late-stage venture financing, growth equity, and public companies. With offices in London, Boston and Menlo Park, Abingworth has backed more than 100 developing life science/medical businesses, over two-thirds of which have gone public, merged, or been acquired. Abingworth has funds under management of more than $1.25 billion. The firm has raised eleven funds since it was founded in 1973, the last nine of which have been entirely dedicated to life sciences and healthcare. Abingworth's investments are based in the U.S. and Europe including the U.K., Belgium, Denmark, France, Germany, Holland and Sweden. The firm's investments range from $15-30 million over more than one round of financing. In February 2014, the firm announced the final closing of its POUND 225M ($375M) fund, Abingworth Bioventures VI (ABV VI). ABV VI is Abingworth's 10th life sciences fund.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Andrew Sinclair Partner
    Genghis Lloyd-Harris Partner
    James Abell Partner and CFO
    John Heard Partner and General Counsel
    Ken Haas Executive Partner


    Recent Funding Events (trailing 12 months):










      Series C





      Series A


    Portfolio companies include:

        web link

        web link

        web link

        web link

      Avila Therapeutics

        web link

      Clovis Oncology
        web link

      Dicerna Pharmaceuticals
        web link

      Effector Therapeutics
        web link

        web link

        web link

      Hydra Biosciences
        web link

      IFM Therapeutics
        web link

        web link

      Lombard Medical Technologies
        web link

      MD On-Line
        web link

        web link

      Proteon Therapeutics
        web link

      SFJ Pharmaceuticals
        web link

        web link

      Stanmore Implants
        web link

        web link

      Tizona Therapeutics
        web link

        web link

      VenatoRx Pharmaceuticals
        web link

      Wilson Therapeutics
        web link


    Recent News:

      There is no recent news for Abingworth.